Abhishek Goyal, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Seasons | 2 | 2019 | 1493 | 0.840 |
Why?
|
Hemochromatosis | 1 | 2020 | 184 | 0.680 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 851 | 0.480 |
Why?
|
Aorta | 1 | 2021 | 2061 | 0.440 |
Why?
|
Urban Population | 2 | 2017 | 2021 | 0.420 |
Why?
|
India | 7 | 2020 | 2197 | 0.420 |
Why?
|
Coronary Vessels | 2 | 2021 | 3107 | 0.410 |
Why?
|
beta Carotene | 1 | 2013 | 527 | 0.410 |
Why?
|
Primary Prevention | 1 | 2018 | 1167 | 0.380 |
Why?
|
Selenium | 1 | 2013 | 405 | 0.370 |
Why?
|
Rural Population | 2 | 2017 | 2210 | 0.360 |
Why?
|
Vitamin A | 1 | 2013 | 615 | 0.360 |
Why?
|
Ascorbic Acid | 1 | 2013 | 651 | 0.360 |
Why?
|
Hypercholesterolemia | 1 | 2016 | 1151 | 0.340 |
Why?
|
Anticholesteremic Agents | 1 | 2016 | 979 | 0.330 |
Why?
|
Circadian Rhythm | 1 | 2019 | 2624 | 0.290 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 3255 | 0.220 |
Why?
|
Cardiovascular Diseases | 4 | 2018 | 15165 | 0.210 |
Why?
|
Shock, Cardiogenic | 2 | 2018 | 688 | 0.200 |
Why?
|
Hypertension | 2 | 2019 | 8480 | 0.190 |
Why?
|
Hospitalization | 1 | 2020 | 10262 | 0.190 |
Why?
|
Mass Screening | 1 | 2016 | 5255 | 0.180 |
Why?
|
Risk Assessment | 3 | 2018 | 23338 | 0.180 |
Why?
|
GPI-Linked Proteins | 1 | 2020 | 434 | 0.170 |
Why?
|
Nutrition Surveys | 2 | 2018 | 1660 | 0.170 |
Why?
|
Coronary Angiography | 3 | 2021 | 4577 | 0.170 |
Why?
|
Aortic Rupture | 1 | 2022 | 310 | 0.160 |
Why?
|
Blood Gas Analysis | 1 | 2019 | 383 | 0.160 |
Why?
|
Aneurysm | 1 | 2021 | 339 | 0.150 |
Why?
|
Coronary Vasospasm | 1 | 2018 | 88 | 0.150 |
Why?
|
Myocardial Stunning | 1 | 2017 | 68 | 0.150 |
Why?
|
Back Pain | 1 | 2022 | 545 | 0.150 |
Why?
|
Catheters | 1 | 2021 | 425 | 0.150 |
Why?
|
Diuretics | 1 | 2020 | 592 | 0.150 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2019 | 236 | 0.150 |
Why?
|
Thymoma | 1 | 2018 | 186 | 0.140 |
Why?
|
Phosphines | 1 | 2016 | 18 | 0.140 |
Why?
|
Heart Failure | 1 | 2020 | 10900 | 0.140 |
Why?
|
Aluminum Compounds | 1 | 2016 | 51 | 0.140 |
Why?
|
Habits | 1 | 2017 | 139 | 0.140 |
Why?
|
Stents | 2 | 2018 | 3280 | 0.140 |
Why?
|
Aspergillosis | 1 | 2017 | 235 | 0.130 |
Why?
|
Morbidity | 2 | 2017 | 1769 | 0.130 |
Why?
|
Eligibility Determination | 1 | 2018 | 403 | 0.120 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2021 | 686 | 0.120 |
Why?
|
Coronary Thrombosis | 1 | 2018 | 495 | 0.120 |
Why?
|
Angina Pectoris | 1 | 2018 | 977 | 0.120 |
Why?
|
American Heart Association | 1 | 2018 | 1056 | 0.110 |
Why?
|
Endocarditis | 1 | 2017 | 350 | 0.110 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2022 | 1186 | 0.100 |
Why?
|
Pacemaker, Artificial | 1 | 2017 | 816 | 0.100 |
Why?
|
Dyslipidemias | 1 | 2019 | 849 | 0.100 |
Why?
|
Prosthesis-Related Infections | 1 | 2017 | 538 | 0.100 |
Why?
|
Adult | 10 | 2020 | 214055 | 0.100 |
Why?
|
Male | 17 | 2022 | 350118 | 0.100 |
Why?
|
Neoplasms, Second Primary | 1 | 2018 | 1061 | 0.090 |
Why?
|
Health Education | 1 | 2017 | 1056 | 0.090 |
Why?
|
Acute Disease | 1 | 2020 | 7149 | 0.090 |
Why?
|
Acute Coronary Syndrome | 1 | 2023 | 2337 | 0.090 |
Why?
|
Middle Aged | 12 | 2019 | 213383 | 0.090 |
Why?
|
Time Factors | 4 | 2019 | 40075 | 0.090 |
Why?
|
Humans | 21 | 2023 | 744343 | 0.080 |
Why?
|
Female | 13 | 2020 | 380194 | 0.080 |
Why?
|
Prospective Studies | 5 | 2019 | 53288 | 0.080 |
Why?
|
Body Mass Index | 2 | 2017 | 12720 | 0.070 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39050 | 0.070 |
Why?
|
Length of Stay | 1 | 2020 | 6309 | 0.070 |
Why?
|
Troponin | 2 | 2023 | 524 | 0.070 |
Why?
|
United States | 5 | 2019 | 69872 | 0.070 |
Why?
|
Risk Factors | 6 | 2019 | 72290 | 0.070 |
Why?
|
Health Behavior | 1 | 2017 | 2636 | 0.060 |
Why?
|
Diabetes Complications | 1 | 2012 | 1359 | 0.060 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2016 | 1354 | 0.060 |
Why?
|
Neoplasms | 1 | 2013 | 21683 | 0.060 |
Why?
|
Sex Factors | 1 | 2018 | 10397 | 0.060 |
Why?
|
Heart | 1 | 2017 | 4467 | 0.060 |
Why?
|
Obesity | 2 | 2019 | 12745 | 0.060 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6487 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 25043 | 0.050 |
Why?
|
Substance-Related Disorders | 1 | 2019 | 4258 | 0.050 |
Why?
|
Smoking | 1 | 2019 | 8987 | 0.050 |
Why?
|
Blood Pressure | 1 | 2017 | 8554 | 0.050 |
Why?
|
Liver Transplantation | 1 | 2012 | 2119 | 0.050 |
Why?
|
Incidence | 2 | 2018 | 20947 | 0.050 |
Why?
|
Age Factors | 1 | 2018 | 18370 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7279 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5751 | 0.050 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2012 | 2214 | 0.050 |
Why?
|
Aortography | 1 | 2022 | 437 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2016 | 3445 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 29063 | 0.040 |
Why?
|
Tachycardia | 1 | 2022 | 619 | 0.040 |
Why?
|
Vena Cava, Inferior | 1 | 2022 | 440 | 0.040 |
Why?
|
Arteriovenous Fistula | 1 | 2022 | 315 | 0.040 |
Why?
|
Young Adult | 2 | 2016 | 56430 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2020 | 77449 | 0.040 |
Why?
|
Diltiazem | 1 | 2018 | 133 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2019 | 11727 | 0.040 |
Why?
|
Cough | 1 | 2021 | 555 | 0.040 |
Why?
|
Aspergillus | 1 | 2017 | 85 | 0.040 |
Why?
|
Electrocardiography | 2 | 2023 | 6442 | 0.040 |
Why?
|
Nitroglycerin | 1 | 2018 | 325 | 0.040 |
Why?
|
Creatine Kinase, MB Form | 1 | 2017 | 214 | 0.040 |
Why?
|
Respiratory Sounds | 1 | 2021 | 696 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2022 | 1850 | 0.040 |
Why?
|
Aged | 6 | 2022 | 163280 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2012 | 4253 | 0.040 |
Why?
|
Histocytochemistry | 1 | 2017 | 719 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 29786 | 0.030 |
Why?
|
Aortic Diseases | 1 | 2022 | 742 | 0.030 |
Why?
|
Hypotension | 1 | 2022 | 884 | 0.030 |
Why?
|
ROC Curve | 1 | 2023 | 3527 | 0.030 |
Why?
|
Aorta, Thoracic | 1 | 2021 | 1082 | 0.030 |
Why?
|
Preventive Health Services | 1 | 2019 | 575 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2018 | 977 | 0.030 |
Why?
|
Pesticides | 1 | 2016 | 287 | 0.030 |
Why?
|
SEER Program | 1 | 2018 | 1508 | 0.030 |
Why?
|
Dyspnea | 1 | 2021 | 1303 | 0.030 |
Why?
|
Water Pollutants, Chemical | 1 | 2016 | 311 | 0.030 |
Why?
|
Age of Onset | 1 | 2019 | 3271 | 0.030 |
Why?
|
Microscopy | 1 | 2017 | 903 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1240 | 0.030 |
Why?
|
Drug-Eluting Stents | 1 | 2018 | 753 | 0.020 |
Why?
|
Brain | 1 | 2017 | 26385 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2023 | 3670 | 0.020 |
Why?
|
Echocardiography | 1 | 2023 | 5102 | 0.020 |
Why?
|
New York City | 1 | 2012 | 710 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2017 | 1573 | 0.020 |
Why?
|
Hemodynamics | 1 | 2017 | 4199 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1797 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8340 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3508 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 19905 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2017 | 5097 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3616 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 7659 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15076 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12788 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6538 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2018 | 63114 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12245 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12354 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2012 | 9239 | 0.010 |
Why?
|